MRSH — MARSH & MCLENNAN COMPANIES, INC.
—
NYSE ·
Financials ·
Insurance ·
CIK 62709 ·
Last close
$170.73
Market Cap
$81.47B
52W High
$204.56
52W Low
$155.72
ADV30
2,615,697
Next earnings
2026-10-15
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 7,404,000,000 | 3,263,000,000 | 1,899,000,000 | 1,266,000,000 | 59,682,000,000 | 1,700,000,000 | 44,249,000,000 |
| Mar 2026 | 7,597,000,000 | 3,467,000,000 | 1,754,000,000 | 1,146,000,000 | 58,552,000,000 | 1,611,000,000 | 43,746,000,000 |
| Dec 2025 | 6,595,000,000 | 2,657,000,000 | 1,219,000,000 | 821,000,000 | 58,710,000,000 | 2,687,000,000 | 43,395,000,000 |
| Sep 2025 | 6,351,000,000 | 2,457,000,000 | 1,170,000,000 | 747,000,000 | 58,783,000,000 | 2,511,000,000 | 43,424,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$5,078,000,000
Investing CF
$-1,015,000,000
Financing CF
$-3,487,000,000
CapEx
$-311,000,000
Dividends Paid
$-1,767,000,000
Buybacks
$-2,905,000,000
EPS Diluted TTM
$8.18
As of
2026-07-26
Balance + Analyst (yfinance extras)
Retained Earnings
$29,301,000,000
Inventory
—
Receivables
$8,943,000,000
ST Investments
—
EBIT TTM
$6,311,000,000
Pretax Income TTM
$5,349,000,000
Interest Exp TTM
$962,000,000
Analysts
21
Yahoo Snapshot (yfinance, live)
Total Revenue
$27,946,999,808
EBITDA
$7,758,000,128
Free Cash Flow
$4,785,249,792
Enterprise Value
$105,355,444,224
Total Cash
$1,700,000,000
Total Debt
$22,382,000,128
Shares Out
477,211,268
Trailing EPS
$8.19
Book Value
$31.77
ROE
25.9%
ROA
7.2%
Div Yield
2.24%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 26,981,000,000 | 6,223,000,000 | 4,160,000,000 | 58,710,000,000 | 43,395,000,000 | 15,100,000,000 | 5,292,000,000 |
| Dec 2024 | 24,458,000,000 | 5,817,000,000 | 4,060,000,000 | 56,481,000,000 | 42,946,000,000 | 13,342,000,000 | 4,302,000,000 |
| Dec 2023 | 22,736,000,000 | 5,282,000,000 | 3,756,000,000 | 48,030,000,000 | 35,660,000,000 | 12,191,000,000 | 4,258,000,000 |
| Dec 2022 | 20,720,000,000 | 4,280,000,000 | 3,050,000,000 | 44,114,000,000 | 33,365,000,000 | 10,520,000,000 | 3,465,000,000 |
TTM Snapshot
Revenues TTM
$22,910,000,000
NetIncome TTM
$3,404,000,000
OpCashFlow TTM
$0
Assets (Latest)
$58,710,000,000
Forward EPS
$11.41
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ELV | Elevance Health, Inc. | $84.32B | $388.82 | — |
| TRV | TRAVELERS COMPANIES, INC. | $74.36B | $356.51 | — |
| CI | Cigna Group | $71.83B | $271.83 | — |
| MFC | MANULIFE FINANCIAL CORP | $70.67B | $42.59 | — |
| MET | METLIFE INC | $59.84B | $94.16 | — |
News headlines (Yahoo Finance, 1h cache)
What You Need to Know Ahead of Marsh & Mclennan’s Earnings Release
2026-09-30 12:11 · Yahoo
Can Archer Help Marsh Tap Growth in Asset-Intensive Reinsurance?
2026-09-29 11:32 · Yahoo
Marsh Appoints Birgit Boykin Chief People Officer of Oliver Wyman and Marsh Management Consulting
2026-09-25 15:07 · Yahoo
Can Marsh Benefit From Changing Asset Owner Priorities?
2026-09-22 16:55 · Yahoo
Is Marsh & McLennan Stock Underperforming the S&P 500?
2026-09-18 06:34 · Yahoo
Marsh to Host Third Quarter Earnings Investor Call on October 15
2026-09-17 16:30 · Yahoo
Insider Sale: CEO Dumps More Than 16,000 Shares of Financial Stock
2026-09-17 14:50 · Yahoo
Can Marsh's AI Strategy Offset Softer Insurance Pricing?
2026-09-17 13:09 · Yahoo
Here's Why Investors Should Hold On to Marsh Stock for Now
2026-09-11 14:19 · Yahoo
2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky
2026-09-29 12:48 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.